Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Aug 6, 2015 · 10-Q · 37 days after period end · 0001193125-15-279829
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$41.85M | -$33.87M | -$19.05M | $8.04M |
| EPS Diluted | -$1.01 | -$0.85 | -$0.60 | $0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 6, 2015 · 37 d after period end
